Illumina appoints Susan E. Siegel to its board of directors

Sue Siegel has joined Illumina, Inc.’s board of directors effective from February 5, 2019. Siegel is chief innovation officer at General Electric (GE) and CEO of GE Ventures. She is responsible for leading the development and acceleration of innovation across GE and built GE Ventures. Siegel has more than 30 years of corporate, entrepreneurial and venture capital experience. Before joining GE, she was a General Partner at Mohr Davidow Ventures, where she led investments in personalized medicine, digital health and life sciences. Prior to that, Siegel served as president and board member at Affymetrix, steering the company’s transformation from a pre-revenue startup to a global genomics leader with a multibillion-dollar market cap. Earlier, she held executive positions spanning functional disciplines at Bio-Rad, DuPont and Amersham.

Share this:

Related Post

Stay Updated on Medical Equipment and Devices industry.
Receive our Daily Newsletter.